References
- RothmanKJGreenlandS1LashTLModern EpidemiologyPhiladelphiaWolters Kluwer Health/Lippincott Williams & Wilkins2008
- KweonSKimYJangMJData resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)Int J Epidemiol2014431697724585853
- SchneeweissSAvornJA review of uses of health care utilization databases for epidemiologic research on therapeuticsJ Clin Epidemiol200558432333715862718
- FranklinJMSchneeweissSWhen and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?Clin Pharmacol Ther2017102692493328836267
- LinKJSchneeweissSConsiderations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugsClin Pharmacol Ther2016100214715926916672
- StergachisASaundersKWDavisRLExamples of Automated DatabasesStromBLKimmelSETextbook of PharmacoepidemiologyChichesterJohn Wiley & Sons2006173214
- TamblynRLavoieGPetrellaLMonetteJThe use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in QuébecJ Clin Epidemiol199548899910097775999
- HerrettEGallagherAMBhaskaranKData Resource Profile: Clinical Practice Research Datalink (CPRD)Int J Epidemiol201544382783626050254
- SchneeweissSRassenJAGlynnRJSupplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatmentsBMC Med Res Methodol201212118023181419
- CarnahanRMMini-Sentinel’s systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future researchPharmacoepidem Drug Safe2012219099
- SuissaSImmeasurable time bias in observational studies of drug effects on mortalityAm J Epidemiol2008168332933518515793
- LinKJGlynnRJSingerDEMurphySNLiiJSchneeweissSOut-of-system Care and Recording of Patient Characteristics Critical for Comparative Effectiveness ResearchEpidemiology201829335636329283893
- SchneeweissSAutomated data-adaptive analytics for big healthcare data to study causal treatment effectsClin Epidemiol20181077178830013400
- RobertsAW1DusetzinaSBFarleyJFRevisiting the washout period in the incident user study design: why 6–12 months may not be sufficientJ Comp Eff Res201541273525565067
- NakasianSSRassenJFranklinJMEffects of expanding the look-back period to all available data in the assessment of covariatesPharmacoepidem Drug Safe201719885810
- RobertsAWDusetzinaSBFarleyJFRevisiting the washout period in the incident user study design: why 6–12 months may not be sufficientJ Comp Eff Res201541273525565067
- ChenGLixLTuKHypertension Outcome and Surveillance TeamInfluence of Using Different Databases and “Look Back” Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services ResearchersPLoS One2016119e016207427583532
- HermanRAGilchristBLinkBKCarnahanRA systematic review of validated methods for identifying lymphoma using administrative dataPharmacoepidem Drug Safe201221203212
- PortaMSGreenlandSHernâanMdos Santos SilvaILastJMA Dictionary of EpidemiologyOxford New YorkOxford University Press2008
- PortaMSGreenlandSHernâanMdos Santos SilvaILastJMA Dictionary of EpidemiologyOxford New YorkOxford University Press2008
- FarrellPMThe prevalence of cystic fibrosis in the European UnionJ Cyst Fibros20087545045318442953
- AdeloyeDChuaSLeeCGlobal Health Epidemiology Reference Group (GHERG)Global and regional estimates of COPD prevalence: Systematic review and meta-analysisJ Glob Health20155202041526755942
- The Truven Health MarketScan Databases for Life Sciences Researchers2017124 Available from: https://truvenhealth.com/Portals/0/Assets/2017-MarketScan-Databases-Life-Sciences-Researchers-WP.pdfAccessed July 25, 2018
- Chronic Obstructive Pulmonary Disease (COPD) Statistics [homepage on the Internet]British Lung Association Available from: https://statistics.blf.org.uk/copdAccessed October 30, 2018
- KhalidJMGlobeGFoxKMChauDMaguireAChiouCFTreatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort studyBMC Dermatol2013131923957883
- BurischJJessTMartinatoMLakatosPLECCO-EpiComThe burden of inflammatory bowel disease in EuropeJ Crohns Colitis20137432233723395397
- RubinGPHunginAPKellyPJLingJInflammatory bowel disease: epidemiology and management in an English general practice populationAliment Pharmacol Ther200014121553155911121902
- KirkbrideJBErrazurizACroudaceTJIncidence of Schizophrenia and Other Psychoses in England, 1950–2009: a Systematic Review and Meta-AnalysesPLoS One201273e3166022457710
- Annual Data Report 2016UK Cystic Fibrosis Registry2017160 Available from: https://www.cysticfibrosis.org.uk/~/media/documents/the-work-we-do/uk-cf-registry/2016-registry-annual-data-report.ashx?la=enAccessed July 25, 2018
- RamsayGQuality and Outcomes Framework – Prevalence, Achievements and Exceptions Report2016143 Available from: https://files.digital.nhs.uk/publicationimport/pub22xxx/pub22266/qof-1516-rep-v2.pdfAccessed June 01, 2018
- SeminaraNMAbuabaraKShinDBValidity of The Health Improvement Network (THIN) for the study of psoriasisBr J Dermatol2011164360260921073449
- GershonASWangCWiltonASRautRToTTrends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based studyArch Intern Med2010170656056520308643
- IcenMCrowsonCSMcEvoyMTDannFJGabrielSEMaradit KremersHTrends in incidence of adult-onset psoriasis over three decades: a population-based studyJ Am Acad Dermatol200960339440119231638
- The Facts About Inflammatory Bowel DiseasesCrohn’s & Colitis Foundation of America2014124 Available from: http://www.crohn-scolitisfoundation.org/assets/pdfs/updatedibdfactbook.pdfAccessed July 25, 2018
- ShivashankarRTremaineWJHarmsenWSLoftusEVJrIncidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010Clin Gastroenterol Hepatol201715685786327856364
- BresnahanMABrownASSchaeferCABeggMDWyattRJSusserESIncidence and cumulative risk of treated schizophrenia in the prenatal determinants of schizophrenia studySchizophr Bull200026229730810885632
- Cystic Fibrosis FoundationAnnual Data Report2016 Available from: https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2016-Patient-Registry-Annual-Data-Report.pdfAccessed July 25, 2018
- American Lung AssociationEstimated Prevalence and Incidence of Lung Disease2014165 Available from: http://www.lung.org/assets/documents/research/estimated-prevalence.pdfAccessed June 01, 2018
- RachakondaTDSchuppCWArmstrongAWPsoriasis prevalence among adults in the United StatesJ Am Acad Dermatol201470351251624388724
- KappelmanMDRifas-ShimanSLKleinmanKThe prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United StatesClin Gastroenterol Hepatol20075121424142917904915
- DesaiPRLawsonKABarnerJCRascatiKLEstimating the direct and indirect costs for community-dwelling patients with schizophreniaJ Pharm Health Serv Res201344187194
- UK Population Estimates [homepage on the Internet]Office of National Statistics; 1851 to 2014 Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationes-timates/adhocs/004356ukpopulationestimates1851to2014Accessed October 30, 2018
- National Population Totals [homepage on the Internet]: US Census Bureau2010–2016 Available from: https://www.census.gov/data/tables/2016/demo/popest/nation-total.htmlAccessed October 30, 2018